Zobrazeno 1 - 10
of 168
pro vyhledávání: '"Makoto, Takei"'
Autor:
Takahiro Suzuki, Mitsunori Miyashita, Takashi Kohno, Jeffrey Rewley, Naoko Igarashi, Maho Aoyama, Michiaki Higashitani, Naoto Kawamatsu, Takeshi Kitai, Tatsuhiro Shibata, Makoto Takei, Kotaro Nochioka, Gaku Nakazawa, Hiroki Shiomi, Shigeru Tateno, Toshihisa Anzai, Atsushi Mizuno
Publikováno v:
BMC Palliative Care, Vol 23, Iss 1, Pp 1-13 (2024)
Abstract Background Outcome measures during acute cardiovascular disease (CVD) phases, such as quality of death, have not been thoroughly evaluated. This is the first study that compared the family members’ perceptions of quality of death in deceas
Externí odkaz:
https://doaj.org/article/ee58ab62c98d430d99dcb0a800b53aa3
Autor:
Yohei Numasawa, Ikuko Ueda, Shun Kohsaka, Yasuyuki Shiraishi, Takashi Kohno, Toshikazu Tanaka, Nobuhiro Ikemura, Makoto Takei, Mitsuyoshi Urashima, Shintaro Nakano, Yuji Nagatomo, Takenori Ikoma, Tomohiko Ono, Munehisa Sakamoto, Kei Nishikawa, Daihiko Hakuno, Ryo Nakamaru
Publikováno v:
BMJ Open, Vol 14, Iss 2 (2024)
Introduction The current guidelines strongly recommend early initiation of multiple classes of cardioprotective drugs for patients with heart failure with reduced ejection fraction to improve prognosis and health status. However, evidence on the opti
Externí odkaz:
https://doaj.org/article/02e2733191234f3c9596bc270483e272
Autor:
Ryo Nakamaru, Shun Kohsaka, Yasuyuki Shiraishi, Takashi Kohno, Ayumi Goda, Yuji Nagatomo, Mitsunobu Kitamura, Shintaro Nakano, Makoto Takei, Atsushi Mizuno, Tsutomu Yoshikawa
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 21 (2023)
Background The management of heart failure (HF) has markedly changed, due to changes in demographics and the emergence of novel pharmacotherapies. However, detailed analyses on the temporal trends in characteristics and outcomes among patients with H
Externí odkaz:
https://doaj.org/article/cf0345fab20640298250a67647b1feb3
Autor:
Ryo Nakamaru, Yasuyuki Shiraishi, Alexander T. Sandhu, Paul A. Heidenreich, Satoshi Shoji, Takashi Kohno, Makoto Takei, Yuji Nagatomo, Shintaro Nakano, Shun Kohsaka, Tsutomu Yoshikawa
Publikováno v:
ESC Heart Failure, Vol 10, Iss 1, Pp 673-684 (2023)
Abstract Aims The long‐term outcome in patients with heart failure (HF) after hospitalization may vary substantially depending on their age and left ventricular ejection fraction (LVEF). We aimed to assess the relative rates of cardiovascular death
Externí odkaz:
https://doaj.org/article/ec796a0a410d424b8867a7cdf3578f15
Autor:
Shohei Imaeda, Yasuyuki Shiraishi, Shun Kohsaka, Nozomi Niimi, Ayumi Goda, Yuji Nagatomo, Makoto Takei, Mike Saji, Shintaro Nakano, Takashi Kohno, Keiichi Fukuda, Tsutomu Yoshikawa
Publikováno v:
ESC Heart Failure, Vol 9, Iss 5, Pp 2967-2977 (2022)
Abstract Aims Furosemide, a short‐acting loop diuretic (SD), is the dominant agent prescribed for heart failure (HF) in clinical practice. However, accumulating data suggests that long‐acting loop diuretics (LD), such as torsemide or azosemide, m
Externí odkaz:
https://doaj.org/article/6957e1fa623a44feac8d31b81c5f0f56
Autor:
Takahiro Jimba, Shun Kohsaka, Masao Yamasaki, Toshiaki Otsuka, Kazumasa Harada, Yasuyuki Shiraishi, Shinji Koba, Makoto Takei, Takashi Kohno, Kenichi Matsushita, Tetsuro Miyazaki, Satoshi Kodera, Shigeto Tsukamoto, Kiyoshi Iida, Akito Shindo, Daisuke Kitano, Takeshi Yamamoto, Ken Nagao, Morimasa Takayama, Tokyo CCU Network Scientific Committee
Publikováno v:
ESC Heart Failure, Vol 9, Iss 5, Pp 2899-2908 (2022)
Abstract Aims Evidence on the association between ambient temperature and the onset of acute heart failure (AHF) is scarce and mixed. We sought to investigate the incidence of AHF admissions based on ambient temperature change, with particular intere
Externí odkaz:
https://doaj.org/article/9f5fb655b7b94f7a98c932d0abaa8061
Autor:
Miyuki Ito, Daichi Maeda, Yuya Matsue, Yasuyuki Shiraishi, Taishi Dotare, Tsutomu Sunayama, Kazutaka Nogi, Makoto Takei, Tomoya Ueda, Maki Nogi, Satomi Ishihara, Yasuki Nakada, Rika Kawakami, Nobuyuki Kagiyama, Takeshi Kitai, Shogo Oishi, Eiichi Akiyama, Satoshi Suzuki, Masayoshi Yamamoto, Keisuke Kida, Takahiro Okumura, Yuji Nagatomo, Takashi Kohno, Shintaro Nakano, Shun Kohsaka, Tsutomu Yoshikawa, Yoshihiko Saito, Tohru Minamino
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract We clarified the association between changes in the number of foundational medications for heart failure (FMHF) during hospitalization for worsening heart failure (HF) and post-discharge prognosis. We retrospectively analyzed a combined data
Externí odkaz:
https://doaj.org/article/7240510585ad47bd8ce68bcb813c508d
Autor:
Shinsuke Takeuchi, Takashi Kohno, Ayumi Goda, Yasuyuki Shiraishi, Masataka Kawana, Mike Saji, Yuji Nagatomo, Yosuke Nishihata, Makoto Takei, Shintaro Nakano, Kyoko Soejima, Shun Kohsaka, Tsutomu Yoshikawa, West Tokyo Heart Failure Registry Investigators
Publikováno v:
ESC Heart Failure, Vol 9, Iss 4, Pp 2500-2510 (2022)
Abstract Aims Multimorbidity is common among heart failure (HF) patients and may attenuate guideline‐directed medical therapy (GDMT). Multimorbid patients are under‐represented in clinical trials; therefore, the effect of multimorbidity clusterin
Externí odkaz:
https://doaj.org/article/9edfd5f79f244d509294431d61f3c204
Autor:
Yumiko Kawakubo, Yasuyuki Shiraishi, Shun Kohsaka, Takashi Kohno, Ayumi Goda, Yuji Nagatomo, Yosuke Nishihata, Mike Saji, Makoto Takei, Yukinori Ikegami, Nozomi Niimi, Alexander Tarlochan Singh Sandhu, Shintaro Nakano, Tsutomu Yoshikawa, Keiichi Fukuda, West Tokyo Heart Failure Registry
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Malnutrition is common in patients with heart failure with reduced ejection fraction (HFrEF) and may influence the long-term prognosis and allocation of combination medical therapy. We reviewed 1231 consecutive patient-level records from a m
Externí odkaz:
https://doaj.org/article/1d80dea477e04a2da8461c076ff12307
Autor:
Ryo Nakamaru, Yasuyuki Shiraishi, Nozomi Niimi, Takashi Kohno, Yuji Nagatomo, Makoto Takei, Takenori Ikoma, Kei Nishikawa, Munehisa Sakamoto, Shintaro Nakano, Shun Kohsaka, Tsutomu Yoshikawa
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 3 (2023)
Background The burden of noncardiovascular conditions is becoming increasingly prevalent in patients with heart failure (HF). We aimed to identify novel phenogroups incorporating noncardiovascular conditions to facilitate understanding and risk strat
Externí odkaz:
https://doaj.org/article/256168016d7c4e4884e3ce32361795d6